Trade GLUE stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Monte Rosa Therapeutics, Inc. (GLUE) is trading at US$10.62, up 3.56% today as of Nov 6, 15:08 EST. The company has a market capitalisation of US$1.22B. Over the past 52 weeks, GLUE has traded between US$9.68 and US$25.77. On Syfe you can trade GLUE with $0 commission and add it to your watchlist.
| Previous close | US$10.25 |
|---|---|
| Market cap | US$1.22B |
| 52-week range | US$9.68 – US$25.77 |
| Volume | 1.5M |
| Exchange | US |
Monte Rosa Therapeutics, Inc.
Monte Rosa Therapeutics, Inc. operates as a biotechnology company, which engages in the developing of precision medicines. The company was founded on November 21, 2019 and is headquartered in Boston, MA.
Year: 2021
Sector Update: Healthcare Stocks Decline Premarket Thursday
Oct 1, 1:17 PM · MT Newswires
Sector Update: Healthcare
Oct 1, 12:59 PM · MT Newswires
Monte Rosa Therapeutics Says MRT-8102 Showed Biomarker Improvements in Phase 1 Study
Oct 1, 12:18 PM · MT Newswires
Monte Rosa Therapeutics, Inc. (GLUE) stock is trading at US$10.62, +3.56% from the previous close of US$10.25.
The market cap for Monte Rosa Therapeutics, Inc. (GLUE) stock is approximately US$1.22B.
The 52-week high for Monte Rosa Therapeutics, Inc. (GLUE) stock is US$25.77.
The 52-week low for Monte Rosa Therapeutics, Inc. (GLUE) stock is US$9.68.
Monte Rosa Therapeutics, Inc. (GLUE) does not currently pay a dividend.
Stay on top of GLUE
Price moves, news and earnings — straight to your inbox.
Snapshot
Popular Stocks in Singapore
